ArticleBlood cancer journal2023

Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma.

Carlyn Rose Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.